The molecular and genetic basis of AD: the end of the beginning: the 2000 Wartenberg lecture.
Rosenberg
R N
RN
Department of Neurology, University of Texas Southwestern Medical Center at Dallas 75390-9036, USA.
D000544:Alzheimer Disease / Q000235:genetics* / Q000628:therapy; D016229:Amyloid beta-Peptides / Q000235:genetics*; D016564:Amyloid beta-Protein Precursor / Q000235:genetics*; D000818:Animals; D001057:Apolipoproteins E / Q000235:genetics; D015316:Genetic Therapy; D006801:Humans; D008565:Membrane Proteins / Q000235:genetics; D051379:Mice; D008822:Mice, Transgenic; D053764:Presenilin-1; D053766:Presenilin-2; D018110:Receptors, Lipoprotein / Q000235:genetics
D016229:Amyloid beta-Peptides; D016564:Amyloid beta-Protein Precursor; D001057:Apolipoproteins E; D008565:Membrane Proteins; C508853:PSEN1 protein, human; C508861:PSEN2 protein, human; D053764:Presenilin-1; D053766:Presenilin-2; D018110:Receptors, Lipoprotein